Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Cyclamic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.91 |
| ▸ | CA7 | P43166 | 3/20 | 0.91 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.91 |
| ▸ | CA9 | Q16790 | 1/20 | 0.91 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclamic Acid SCHEMBL28963281 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL692781 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL2188654 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL9591547 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL414415 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL66221 | 0.95 | CA12 (1.00) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL1532404 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL10856451 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL1457947 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL28154733 | 0.95 | CA12 (1.00) | CA12CA7CA14CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3510010-B1 | TASTE MODULATING ALDEHYDE | TAKASAGO PERFUMERY CO LTD (JP) | 2023-09-06 | — | — | EP | claimed |
| US-11540542-B2 | Taste modulating aldehydes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-01-03 | — | — | US | claimed |
| EP-1919439-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | The Procter and Gamble Company (US) | 2008-05-14 | — | — | EP | claimed |
| EP-1919440-A2 | AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER | The Procter and Gamble Company (US) | 2008-05-14 | — | — | EP | claimed |
| US-20070231283-A1 | Process for bleaching keratin fibers | PROCTER & GAMBLE COMPANY, THE | 2007-10-04 | — | — | US | claimed |
| US-20070067925-A1 | Agent for simultaneously lightening and coloring of fibers | PROCTER & GAMBLE COMPANY, THE | 2007-03-29 | — | — | US | claimed |
| WO-2007026327-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | claimed |
| WO-2007026328-A2 | AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | claimed |
| EP-1759685-A1 | Agent for simultaneous lightening and coloring of keratin fibres containing a sulfamate bleach booster | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | claimed |
| EP-1759684-A1 | Process for bleaching keratin fibers | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | claimed |
| EP-4642439-A1 | A STABLE READY TO USE SUSPENSION OF STIRIPENTOL | Kinedexe UK Limited (GB) | 2025-11-05 | — | — | EP | disclosed |
| EP-4473977-A2 | PHARMACEUTICAL COMPOSITION IN THE FORM OF A CHEWABLE TABLET OF DIOSMIN OR A FLAVONOID FRACTION COMPRISING SAME | Les Laboratoires Servier (FR) | 2024-12-11 | — | — | EP | disclosed |
| EP-3823588-B1 | PHARMACEUTICAL COMPOSITION IN THE FORM OF A CHEWABLE TABLET OF DIOSMIN OR OF A FLAVONOID MOIETY COMPRISING DIOSMIN | SERVIER LAB (FR) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024141890-A1 | A STABLE READY TO USE SUSPENSION OF STIRIPENTOL. | Kinedexe UK Limited (GB) | 2024-07-04 | — | — | WO | disclosed |
| EP-4352110-A1 | METHOD FOR MODIFYING STARCH BY HYDROTHERMAL TREATMENT, STARCH OBTAINED BY THIS METHOD AND USES THEREOF | INNOVI (FR) | 2024-04-17 | — | — | EP | disclosed |
| WO-2007026327-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007026328-A2 | AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | disclosed |
| EP-1759685-A1 | Agent for simultaneous lightening and coloring of keratin fibres containing a sulfamate bleach booster | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | disclosed |
| EP-1759684-A1 | Process for bleaching keratin fibers | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | disclosed |
| CN-1144627-A | Sweetening agent and its production method | MIAO CHENLIN (CN) | 1997-03-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070067925-A1 | Agent for simultaneously lightening and coloring of fibers | KIT, KRT18, H1-5 | CA12 130/4885CA7 80/4885CA14 186/4885 |
| US-11540542-B2 | Taste modulating aldehydes | TAS2R10, TAS2R50, TAS2R1 | CA12 1081/4885CA7 1892/4885CA14 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.